Skip to main content

Investor RelationsWealth Management:  CA  |  UK  |  AU

Menu

BEIJING | CHINA

Partnering to deliver
global solutions
tailored to your unique needs

Transactions

Our corporate finance solutions are tailored to our clients’ strategic goals and delivered based on in depth expertise across a wide range of sectors globally. We have a strong track record, participating in 187 transactions and raising C$19.5 Billion on behalf of our clients in Q3/20211.2.

Filter our transactions* using the categories below:

Velocity Acquisition Corp.
US$230m
February 2021

Velocity Acquisition Corp.

Joint Bookrunner (IPO)
SPACS EQUITY CAPITAL MARKETS US
Dye & Durham
C$630m
February 2021

Dye & Durham

Lead Left Bookrunner (Follow-on & Convertible Debenture)
TECHNOLOGY EQUITY CAPITAL MARKETS CANADA
Osisko Mining
US$70m
February 2021

Osisko Mining

Lead Left Bookrunner (Private Placement)
METALS AND MINING EQUITY CAPITAL MARKETS US
MicroStrategy Incorporated
US$1b
February 2021

MicroStrategy Incorporated

Co-Manager (144a Convert)
TECHNOLOGY EQUITY CAPITAL MARKETS US
Revive Therapeutics Ltd.
C$23m
February 2021

Revive Therapeutics Ltd.

Co-Lead Bookrunner (Equity Financing)
CANNABIS HEALTHCARE EQUITY CAPITAL MARKETS CANADA
Travere Therapeutics Inc.
US$175m
February 2021

Travere Therapeutics Inc.

Lead Manager (Follow-on)
HEALTHCARE EQUITY CAPITAL MARKETS US
View transaction detail
Quixant PLC
£80m
February 2021

Quixant PLC

Joint Broker
TECHNOLOGY GAMING CORPORATE BROKING UK
View transaction detail
Jushi
C$75m
February 2021

Jushi

Co-Lead Bookrunner (Equity Financing)
CANNABIS HEALTHCARE EQUITY CAPITAL MARKETS CANADA
Kaledio
US$69m
February 2021

Kaledio

Lead Manager (Follow-On)
HEALTHCARE EQUITY CAPITAL MARKETS US
View transaction detail
Jet2.com
£422m
February 2021

Jet2.com

Joint Global Coordinator, Joint Bookrunner and Joint Broker (Placing and Retail Offer)
INDUSTRIALS/AEROSPACE & DEFENSE AEROSPACE & DEFENCE CORPORATE BROKING EQUITY CAPITAL MARKETS UK
Bioventus Inc.
US$120m
February 2021

Bioventus Inc.

Lead Manager (IPO)
HEALTHCARE EQUITY CAPITAL MARKETS US
Viant Technology, Inc.
US$288m
February 2021

Viant Technology, Inc.

Co-Manager (IPO)
TECHNOLOGY EQUITY CAPITAL MARKETS US